Dr. Giugliano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
TIMI Study Office, Hale BTM Suite 7022, 60 Fenwood Road
Brigham And Womens Hospital Cardiovascualar Division
Boston, MA 02115Phone+1 617-278-0317Fax+1 617-264-5130- Is this information wrong?
Education & Training
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1993 - 1996
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 1989 - 1993
- Harvard Medical SchoolClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - Present
- MA State Medical License 1993 - 2024
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Emergent Coronary Thrombectomy for Acute Myocardial Infarction Immediately Following Craniotomy with Tumor Resection.Giselle A Suero-Abreu, Curtis R Ginder, Saad S Ghumman, Brian A Bergmark, Omar Arnaout, Robert P Giugliano> ;Cardiology and Therapy. 2024 Mar 27
- Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis.Aeron M Small, Giorgio E M Melloni, Frederick K Kamanu, Brian A Bergmark, Marc P Bonaca, Michelle L O'Donoghue, Robert P Giugliano, Benjamin M Scirica, Deepak Bhatt, E...> ;JAMA Cardiology. 2024 Apr 1
- Optimizing warfarin dosing for patients with atrial fibrillation using machine learning.Petch, J., Nelson, W., Wu, M., Ghassemi, M., Benz, A., Fatemi, M., Di, S., Hong, H., Wallentin, L., Eikelboom, J., Connolly, S., Carnicelli, A., Granger, C., Giugliano...> ;Scientific Reports. 2024 Feb 24
- Join now to see all
Journal Articles
- Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction with Statins, Ezetimibe, and PCSK9 InhibitionRobert P Giugliano, Marc S Sabatine, JAMA Cardiology
- Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin TherapyPrakash Deedwania, Narimon Honarpour, Marc S Sabatine, Robert P Giugliano, JAMA Cardiology
- Efficacy of Evolocumab on Cardiovascular Outcomes in Patients with Recent Myocardial InfarctionChristopher E Kurtz, Narimon Honarpour, Marc S Sabatine, Robert P Giugliano, JAMA Cardiology
Authored Content
- Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin TherapyAugust 2020
- Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin TherapyAugust 2020
- Efficacy of Evolocumab on Cardiovascular Outcomes in Patients with Recent Myocardial InfarctionMay 2020
- Efficacy of Evolocumab on Cardiovascular Outcomes in Patients with Recent Myocardial InfarctionMay 2020
- The Nonalcoholic Fatty Liver Disease (NAFLD) Fibrosis Score, Cardiovascular Risk Stratification and a Strategy for Secondary Prevention with EzetimibeMay 2018
- Oral Anticoagulation in Patients with Liver DiseaseMarch 2018
- Clinical Events After Interruption of Anticoagulation in Patients with Atrial Fibrillation: An Analysis from the ENGAGE AF-TIMI 48 Trial☆February 2018
- Clinical Events After Interruption of Anticoagulation in Patients with Atrial Fibrillation: An Analysis from the ENGAGE AF-TIMI 48 Trial☆February 2018
- Join now to see all
Press Mentions
- Association Between Changes in Serial Values of hsTn, Subsequent Cardiovascular EventsJanuary 23rd, 2023
- New Analysis Finds Broader Benefit for Post ACS Ezetimibe-Statin ComboOctober 5th, 2021
- Post-ACS Patients with Low LDL Levels Remain at Risk: IMPROVE-ITOctober 4th, 2021
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: